SCHEMBL8618596

SCHEMBL8618596

C=CC(O)c1ccc(-c2ccc(CCCCC)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 6/20 0.50
THRB P10828 5/20 0.49
THRA P10827 4/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
ALDH1A1 P00352 2/20 0.49
RARA P10276 2/20 0.49
MAPT P10636 1/20 0.49
MTOR P42345 1/20 0.49
LPL P06858 4/20 0.47
LIPG Q9Y5X9 4/20 0.47
HSD17B10 Q99714 2/20 0.46
TSHR P16473 1/20 0.46
TRPV1 Q8NER1 1/20 0.46
MGLL Q99685 1/20 0.46
ESR1 P03372 2/20 0.46
ADRA2A P08913 2/20 0.46
ADORA3 P0DMS8 2/20 0.46
TACR2 P21452 2/20 0.46
SLC6A2 P23975 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8625001 0.94 THRB (0.54) THRBTHRAMEN1KMT2AALDH1A1
SCHEMBL8623292 0.89 THRB (0.45) RARBTHRBTHRAMEN1KMT2A
SCHEMBL12035890 0.80 CSNK1E (0.44) RARBTHRBTHRAMEN1KMT2A
SCHEMBL12035888 0.80 CSNK1E (0.44) RARBTHRBTHRAMEN1KMT2A
SCHEMBL10333376 0.80 RARB (0.56) RARBMEN1KMT2AALDH1A1RARA
SCHEMBL9805784 0.80 RARB (0.56) RARBMEN1KMT2AALDH1A1RARA
SCHEMBL9498807 0.79 RARB (0.54) RARBMEN1KMT2AALDH1A1RARA
SCHEMBL9498972 0.78 RARB (0.55) RARBMEN1KMT2AALDH1A1RARA
SCHEMBL9498582 0.78 RARB (0.55) RARBMEN1KMT2AALDH1A1RARA
SCHEMBL9498408 0.78 RARB (0.55) RARBMEN1KMT2AALDH1A1RARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5712396-A PHOSPHONOSULFONATE COMPOUNDS USED FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND ATHEROSCLEROSIS MAGNIN DAVID R (US) 1998-01-27 US disclosed
US-5567841-A ANTICHOLESTEROL AGENT BRISTOL-MYERS SQUIBB COMPANY (US) 1996-10-22 US disclosed
US-5470845-A Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia BRISTOL-MYERS SQUIBB COMPANY (US) 1995-11-28 US disclosed